Navigation Links
PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
Date:9/24/2008

e time treatment was initiated. The AGM model, which we have been developing with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) is believed to closely mimic the disease course of inhalational anthrax infection in humans. In this therapeutic model, treatment with Valortim(R) is begun only after anthrax toxin is first detected in the circulation. This model may provide an important improvement over existing therapeutic models for anthrax by precisely defining a standardized timing for therapeutic intervention," commented Mr. Wright.

About Valortim(R)

Valortim(R) is a fully human antibody designed to protect against inhalation anthrax, the most lethal form of illness in humans caused by the Bacillus anthracis bacterium. The investigational antibody is designed to target a protein component known as the anthrax protective antigen of the lethal toxin complex produced by the bacterium. The anthrax protective antigen is believed to initiate the onset of the illness by attaching to cells in the infected person, and then is believed to facilitate the entry of additional destructive toxins into the cells. Valortim(R) is designed to target anthrax protective antigen and protect the cells from damage by the anthrax toxins.

About Protexia(R)

Protexia(R) is a recombinant version of human butyrylcholinesterase (BChE), a naturally occurring protein found in minute quantities in blood (2 mg/liter). BChE functions as a natural bioscavenger, like a sponge, to absorb and degrade organophosphate poisons (e.g. nerve agents) before they cause neurological damage. Protexia(R) is being developed as a pre- and post-exposure therapy for casualties on the battlefield or civilian victims of nerve agent attacks. Nerve agents belong to a class of compounds known as organophosphate (OP) agents. OP nerve agents, such as sarin gas, soman, tabun or VX, enter the blood stream via inhalation or absorption through the skin. The nerve agen
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... April 28, 2015  BioDelivery Sciences International, Inc. ... DeRossett , MD, PhD to the position of ...  Dr. DeRossett joins BDSI with nearly twenty-five years ... neurosciences area.  Dr. DeRossett will oversee clinical research ... as the medical support for BDSI,s currently marketed ...
(Date:4/28/2015)... , April 28, 2015 Anteo ... providing powerful new tools developed with their patented ... traditional coupling methods, helping to improve medical devices ... disease. Increasingly complex multifactorial diagnosis of ... its limits. It is restricted to measure only ...
(Date:4/28/2015)... 2015 We are living a connected life in ... world and very soon we will be able to connect ... connected life market has been valued by Frost & Sullivan ... to drive and manage this change to stay ahead of ... Highlights of the congress include a groundbreaking keynote address ...
Breaking Medicine Technology:BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 2BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 3BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs 4Faster Detection of Disease: Anteo is Transforming The Way Scientists Work with Luminex(R) xMAP(R) 2Faster Detection of Disease: Anteo is Transforming The Way Scientists Work with Luminex(R) xMAP(R) 3Frost & Sullivan's GIL 2015 Unveils the $700 Billion Connected Life Market 2Frost & Sullivan's GIL 2015 Unveils the $700 Billion Connected Life Market 3
... Nov. 2, 2011 LORENZ customers and business partners have ... Article 57(2) of Regulation (EC) 726/2004 and its impact on ... Interest Group for EVMPD – XEVPRM. One of ... registration are the Requirements of Article 57(2) of Regulation (EC) ...
... GenVec, Inc. (Nasdaq: GNVC ) will report financial ... 9, 2011, before the U.S. financial markets open. The announcement ... 10:00 a.m. EST to discuss the company,s third quarter financial ... the live conference call, please dial 877-558-0567 (U.S. or Canada) ...
Cached Medicine Technology:LORENZ' Response to New EU PV Legislation - Regulation No. 1235/2010 and EVMPD 2GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011 2
(Date:4/28/2015)... 2015 New and more complex ... of manufacturers, payers, pharmacists and patients. Now Specialty ... is partnering with the National Association of Specialty ... solely to this developing field to better equip ... need. , “This partnership creates a powerful platform ...
(Date:4/28/2015)... Celebrating women has become a tradition at ... third year that all things mom and female will be ... is offering some great specials Special discounts ... year could there be to focus on woman," states Marla ... this is a terrific time for it. And the special ...
(Date:4/28/2015)... Louis, Missouri (PRWEB) April 28, 2015 ... report that delves into the reality problem Americans have ... the population will need long-term care services as they ... need such care. , In the report, Carol ... organizations such as the American Health Care Association and ...
(Date:4/28/2015)... April 28, 2015 Once considered an unproven ... have taken the industry by storm with perfectly tailored light ... unit. , More than half of every SuperCloset ... LED , proving the stigma is gone and LED Grow ... positive response from customers and their first hand experience using ...
(Date:4/28/2015)... 28, 2015 The west coast, south, ... the top areas that healthcare professionals searched for jobs ... the month of March 2015. Data was released ... travel nurse jobs , physical therapy jobs , ... and allied health fields. , States with ...
Breaking Medicine News(10 mins):Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Commack Massage Therapy and Wellness Day Spa Dedicates Time To Celebrate Women 2Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:Hot States for Medical Careers: Healthcare Staffing Agency Aureus Medical Releases Online Search Results 2
... A study published in the July edition of the ... // number and severity of cases of constriction of ... ,Normally constriction of blood vessels occurs ... to strokes and neurological deficits. This can cause not ...
... you away from making an appointment with your// dentists, then ... how you’ve thought before. New advancement in dentistry can cause ... you can get all your dental work done while being ... ,The process of dental sedation is done through sedating ...
... guidance titled "Pharmacogenomic Data Submissions" to speed// development ... pharmacogenomics. ,Pharmacogenomics allows health care providers to ... response and predict the best possible treatment option ... development of targeted therapies like Herceptin for metastatic ...
... the land of mystic magic, serine breath taking beauty, and the ... side of humanity. However there is more to this large ... ,The AIDS virus has been silently threatening all of Asia. Its ... in Asia every day. 1,500 persons effected with the virus die ...
... the health journal Epidemiology has published a major retrospective study ... if there is associated infertility. ,Dr. Louise A. ... team followed 12,193 U.S. women treated for infertility between ... with that of the general population. The women were followed ...
... comet assay has gained rapid importance in detecting various ... have numerous disadvantages and are time consuming, resource intensive ... ,The comet assay attracts adherents by it’s simplicity, speed, ... in-vivo study. The Comet assay can be used to ...
Cached Medicine News:Health News:Clazosentan May help to Improve Blood Circulation after Brain Hemorrhage due to burst Aneurysm 2Health News:Advent of New, More Effective and Personalized Medicines 2Health News:AIDS - The ‘silent but lethal tsunami’ of Asia 2Health News:Detecting DNA Damage With In-Vivo Alkaline Comet Assay 2
... color touch screen shows you the ... cassette it is ready-to-go in any ... assures accurate calibration prior to each ... with a removable, rechargeable battery, which ...
... The ABL800 FLEX is a fully ... most advanced blood gas analyzer along ... gives you the freedom to focus ... FLEX provides features that are essential ...
Flatbed Agitator....
Flatbed Agitator....
Medicine Products: